Bluesky Facebook Reddit Email

Medical crowdfunding for treatments unsupported by evidence or potentially unsafe

10.23.18 | JAMA Network

SAMSUNG T9 Portable SSD 2TB

SAMSUNG T9 Portable SSD 2TB transfers large imagery and model outputs quickly between field laptops, lab workstations, and secure archives.

Bottom Line: Medical crowdfunding is using social media to appeal for help in paying for medical care. These campaigns can fill insurance gaps but they can also raise money for scientifically unsupported, ineffective or potentially dangerous treatments. This study examined crowdfunding activity for five such treatments since November 2015 and identified more than 1,000 campaigns that raised nearly $6.8 million. The campaigns collected money for homeopathic or naturopathic cancer treatments, hyperbaric oxygen therapy for brain injury, stem cell therapies for brain and spinal cord injury, and long-term antibiotic therapy for chronic Lyme Disease. Limitations of the study include only five treatments and four crowdfunding platforms were analyzed.

Authors: Ford Vox, M.D., Brain Injury Rehabilitation, Shepherd Center, Atlanta, and coauthors

To Learn More: The full study is available on the For The Media website .

(doi:10.1001/jama.2018.10264)

Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

###

JAMA

Keywords

Article Information

Contact Information

How to Cite This Article

APA:
JAMA Network. (2018, October 23). Medical crowdfunding for treatments unsupported by evidence or potentially unsafe. Brightsurf News. https://www.brightsurf.com/news/LNM550K1/medical-crowdfunding-for-treatments-unsupported-by-evidence-or-potentially-unsafe.html
MLA:
"Medical crowdfunding for treatments unsupported by evidence or potentially unsafe." Brightsurf News, Oct. 23 2018, https://www.brightsurf.com/news/LNM550K1/medical-crowdfunding-for-treatments-unsupported-by-evidence-or-potentially-unsafe.html.